• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
              Advocacy & Research for Unlimited Lifespans


How to live to 150: The 3 horizons of longevity tech with Sergey Young

sergey young longevity horizons

  • Please log in to reply
No replies to this topic

#1 Engadin

  • Guest
  • 197 posts
  • 565
  • Location:Madrid
  • NO

Posted 23 September 2020 - 08:41 AM








S O U R C E :   The ChalkBoard Magazine









SERGEY YOUNG plans to live to the age of 200. And he’s not the first. Wellness is buzzing with the kinds of bio-hacks and breakthroughs that have health researchers like Sergey and the likes of Bulletproof’s Dave Asprey planning on a longer lifespan than many of us ever dreamed.  
As a longevity investor, meaning he invests in the kind of technologies designed to extend the quality and quantity of our lives, Sergey is on the cutting edge of many fascinating and, frankly, mind-boggling medical technologies.
We asked Sergey to talk to us about the top tech in each of the three longevity “horizons”, which he breaks down below. His mission? To help one billion people extend their healthy lifespans by making longevity affordable and accessible. The Longevity Vision Fund is his personal passion project, built to fund and accelerate life extension breakthroughs and to make them affordable and accessible to all. Sergey is one of few investors in the category globally and some of his investments might surprise you …
The 3 Horizons of Longevity
The three horizons of longevity provide a ‘map’ of breakthrough longevity innovations that Sergey and team use as a model:
HORIZON 1 – technology already available that has the potential to expand our lifespans to 100 years.
HORIZON 2 – technology available over the next 5-10 years with the potential to expand our lifespans to 150 years.
HORIZON 3 – technology available over the next 10-20 years with the potential to expand our lifespans to 200 years.
 Studies of autopsies suggest doctors misdiagnose fatal illnesses around 20% of the time, including diagnoses that were simply delayed.
 Artificial Intelligence is helping doctors make earlier and more accurate diagnoses. Early diagnostics are crucial, as they can mean recovery rates of over 90% from certain types of cancer.
 AI is also helping doctors to save time during diagnostics, which can enable more patients to be seen. For example, it takes just 4 seconds to analyze a patient’s heart function on a cardiac RI scan using AI, while a human doctor without AI requires 13 minutes on average.
 Freenome, a Longevity Vision Fund portfolio company, is working on early non-invasive diagnostics of colon cancer using blood tests. It has demonstrated 100% sensitivity (the ability to correctly classify an individual as ′diseased′) for colorectal cancer testing using its multiomics platform, whereas the current standard test (fecal immunochemical test) only achieved 67% sensitivity.
 Doctors using Google’s AI tool LYNA are better at detecting advanced breast cancer (99% accuracy) than human doctors alone (as low as 38% accuracy) – even when looking for
extremely small metastases human pathologists might miss.
 About 60% of consumers agree that wearables put them in control of their health and lead to healthier lifestyles.
 Growing adoption of wearables at relatively accessible prices and advanced functions resulted in the development of a whole new area of preventive healthcare.
 AppleWatch can save lives by monitoring your heart health via an ECG or calling an ambulance if it registers a hard fall.
 FitBit can help manage stress by tracking your HRV (heart rate variability) and reminding you to take a break and walk around every hour.
 Amazon’s new health & wellness band HaloBand can help control your weight by measuring your body fat percentage using a 3D body scan, which is considered ‘a better indicator of health than weight or BMI alone’.
 Telemedicine allows caring for patients remotely via video conference tools. It is helping to bridge the gap between people and doctors across different geographies and income levels, and facilitates access to healthcare for people who are symptomatic or disabled.
 Coronavirus has accelerated the adoption of telemedicine by helping to reduce the spread of the virus and protect medical staff. Hospitals are quickly adopting telehealth to treat quarantined patients. At the onset of the pandemic, The White House even lifted Medicare telemedicine restrictions, allowing more providers to accept Medicare payments for virtual visits.
 Teladoc Health, now used by more than 40% of Fortune 500 employers, is becoming a crucial feature in corporate health & wellness programs at companies such as Accenture.
 Microsoft Teams enables telemedicine by providing secure collaboration solutions via chat, voice, and video between medical professionals in a single hub that supports key compliance requirements (in addition to remote appointments with patients).
 Health supplements can now be customized according to your dietary needs, beliefs, and preferences with the help of companies offering 3D-printing technology, online subscriptions, and online quizzes to tailor the pills you take.
 Not only can the nutritional content of pills be personalized, but so can the time when each component is released. For example, people who skip breakfast as part of their intermittent fasting routine and go to bed early can design a capsule that delivers some caffeine and essential nutrients in the morning, and a blend of relaxing and sleep-promoting herbs in the early evening.
 Multiply Labs uses 3D-printing technology to personalize not only the nutritional content of the pills, but also the time when each component is released.
 The time-release factor is achieved by 3D-printing a capsule with separate compartments of varying thickness. For example, a compartment with a thin wall might release the product within 30 minutes, while another thicker compartment in the same capsule, but is capable of containing the supplement for at least two hours.
 Nourish3d is another 3D supplement-printing company, which provides customizable vegan, sugar-free, made-to-order “stacks” (that look and taste like fruit gummies) on a flexible subscription basis and with delivery to home and work addresses.
 Bioniq starts you off with a comprehensive blood assessment that not only assesses your nutritional requirements to build your personalized daily vitamin formula. Monthly blood tests allow to modify nutritional content of your pack to satisfy your body’s changing needs.




 The development of a new drug is estimated at $2.6B. A lot of that money is effectively wasted, as it is spent on the 9 out of 10 candidate therapies that fail somewhere between phase I trials and regulatory approval.
 Artificial intelligence is transforming drug discovery, making the search for new pharmaceuticals quicker, cheaper and more effective.
 Insilico Medicine, a Longevity Vision Fund portfolio company specializing in AI-based drug discovery, is capable of designing, synthesizing and identifying a new drug target in just 46 days – in comparison to 2-3 years typically required using big pharma’s standard approach without the support of this technology.
 Insilico Medicine also demonstrated its ability to identify thousands of new molecules targeting the key coronavirus protein in just 4 days, which could serve as potential medications.
 Schrodinger is another drug discovery company that is helping to advance COVID-19 drug discovery efforts. In has partnered with Google Cloud, which is giving Schrödinger access to its powerful computing capacity to accelerate discovery for its commercial partners and its internal pipeline.
 Gene therapies alter an organism’s DNA by allowing therapeutic genetic material to be added, altered or removed. Given the abundance of diseases where improper functioning of genes plays an important role, gene therapy is a game changer and has already proved to be lifesaving.
 Novartis is one of the companies pioneering gene therapy space. Its Zolgensma is one of the first gene therapies to be approved and is the first and only gene therapy for children with spinal muscular atrophy. Zolgensma was approved in 2019 and is already helping to save lives.
 4DMT (another Longevity Vision Fund portfolio company) is a gene therapy company developing next-generation gene therapies, more safe and effective. It is using ‘directed evolution’ technology – a method, which mimics the process of natural selection towards a certain goal, without waiting for random variations to occur over thousands of generations.
 Cell therapy is a treatment where viable cells are injected or implanted into the patient’s body to achieve a therapeutic effect – for example, by transplanting immune cells capable of fighting cancer cells or grafting stem cells to regenerate diseased tissues.
 Approved therapies include Kymriah (by Novartis) and Yescarta (by Gilead), which help treat hematologic cancers in children.
 Sigilon Therapeutics (a Longevity Vision Fund portfolio company) develops an encapsulated cell therapy platform based on a new class of therapeutics.
 It can produce a wide range of proteins to treat serious chronic disorders in a durable, controllable, and safe way without generating immune rejection or fibrosis.
Horizon 3
 The need for human organs far outpaces their availability, with more than 20 people dying each day awaiting a transplant. There are over 110,000 people on waiting lists in the U.S alone.


Also tagged with one or more of these keywords: sergey young, longevity, horizons

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users